The French health system studies project takes protesa mammary the country

The French health system studies project takes protesa mammary the country

A study by the Cancer Institute of France, released on Tuesday (17), reveals that breast implants can cause a rare type of tumor in the lymphatic system.
Due to the conclusions of experts, the French government is currently studying the prohibition of breast implants in the country.
Researchers from the National Cancer Institute (NCI) of France revealed the existence of a new disease, "anaplastic large cell lymphoma associated with a breast implant (ALCL-AIM)" and proposes that this cancer be included in the classification diseases of the World Health Organization (WHO).
"There is a clearly established link between the emergence of this disease and the use of a breast implant," says the report by the French Institute. "This cancer was not diagnosed in any woman without prostheses in the breasts."
French oncologists estimate that the risk of lymphoma in women with breast implants is 200 times higher than in the general female population.
They point out, however, that the frequency of the medical complication is very low. Since 2011, only 18 women developed this cancer in France (one of them is dead), according to the INC.
Surveillance
The study was conducted at the request of the French authorities of health after the rapid increase of cases of this cancer in a relatively short period.
Although the number of affected people still be very limited, which worries the authorities is the speed of progression: the total number of new cases increased from two in 2012 to 11 last year.
The Health Minister Marisol Touraine said on Tuesday that women with breast implants "do not have to remove them" and should not be "overly concerned".
"Our vigilance is total," the minister said, adding that any breast implant brand is being targeted specifically in relation to the discovery of this new tumor.
Touraine also stated that the information to women wishing to place breast implants will be strengthened.


SHORT THE WELL-BEING

The National Agency of Drug Safety (MSNA) of France has announced that women who wish to put implants in the breasts should be "necessarily alerted about this new venture, even though he is down," he said in an interview with Le Parisien newspaper, François Hébert, deputy director general of the agency.
According to him, information documents and alerts on the issue have been sent to physicians in the country. "If you need to ban the implants, we will," said the director of MSNA.
The French agency will meet with experts later this month to decide on the matter. A possible ban of the prosthesis will depend on the conclusions of the researchers.
"The signs are compelling. The cases increase. We are exchanging information with the FDA (Food and Drugs Administration) American," says Professor Benoit Vallet, Director General of Health, which determines the French public policies in the area.
"Health professionals should be more vigilant against this risk. Women who wear dentures should be examined by a doctor every year."
Scandal
The discovery of new risks involving breast implants is only five years after the scandal of the French brand PIP prostheses, which shocked the country. They were produced with a silicone gel not authorized for medical purposes and fuel containing no additive tested for clinical use.
The PIP was the world's third largest manufacturer of breast implants and exported to many countries, including Brazil. According to the MSNA, about 400,000 women in France have prosthetic breasts, 80% of them for aesthetic reasons.
g1 source